| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 02/20/1992 | WO1992002620A1 Chimeric neurotrophic factors |
| 02/20/1992 | WO1992002558A1 Method of purifying cytokeratin 20, and the use of cytokeratin 20 to produce antibodies |
| 02/20/1992 | WO1992002553A1 Tumor cell binding molecule with protease inhibiting region |
| 02/20/1992 | WO1992002550A1 Expression of recombinant polypeptides with improved purification |
| 02/20/1992 | CA2088990A1 Chimeric neurotrophic factors |
| 02/19/1992 | EP0471205A1 Monoclonal antibodies which bind TRK proto-oncogene protein |
| 02/18/1992 | US5089605 Immobilized immunoglobulin-binding proteins |
| 02/18/1992 | US5089603 Antigenic epitopes present on membrane-bound but not secreted iga |
| 02/16/1992 | CA2048244A1 Monoclonal antibodies which bind trk proto-oncogene protein |
| 02/12/1992 | EP0470165A1 Fusion proteins containing n-terminal fragments of human serum albumin |
| 02/11/1992 | CA1295567C Expression system for the secretion of bioactive human granulocyte, macrophage-colony stimulating factor (gm-csf) and other heterologous proteins from streptomyces |
| 02/06/1992 | WO1992001707A1 Purification directed cloning of peptides |
| 02/06/1992 | WO1992001470A1 Target specific antibody-superantigen conjugates and their preparation |
| 02/05/1992 | EP0469281A1 Amino acid residue sequence of hepatitis B core antigen |
| 02/05/1992 | EP0193585B1 Cross-reactive and protective epitopes of circumsporozoite proteins |
| 02/04/1992 | US5085862 Mutants, vaccine; immunoprotective in mice |
| 02/03/1992 | WO1992002817A1 Adhesion receptors for pathogenic or opportunistic microorganisms |
| 02/01/1992 | CA2048029A1 Amino acid residue sequence of hepatitis b core antigen |
| 01/30/1992 | DE4107765A1 Pankreas-elastase-1-spezifischer antikoerper, ein verfahren zu seiner gewinnung und ein testkit der solche antikoerper enthaelt Pancreatic elastase-1-specific antibodies, a process for its production and to a test kit which such antibody contains |
| 01/30/1992 | DE4023945A1 Verfahren zur reinigung von cytokeratin 20 und dessen verwendung zur erzeugung von antikoerpern A process for purification of cytokeratin 20 and its use for the production of antibodies |
| 01/29/1992 | WO1992002630A1 Pancreas-elastasis-1-specific antibody, a process for obtaining it and a test kit containing such antibodies |
| 01/29/1992 | EP0468714A2 Peptide-polysaccharide-protein conjugate vaccines |
| 01/29/1992 | EP0468601A1 Methods and materials for HIV detection and therapy |
| 01/29/1992 | EP0467987A1 Methods and materials for expression of human plasminogen in a eukaryotic cell system |
| 01/28/1992 | US5084391 Monoclonal antibody to the interleukin-2-receptor and its use |
| 01/25/1992 | WO1992001790A1 Endogenously sweetened transgenic plant products |
| 01/25/1992 | WO1992001469A1 A composition providing improved clearance of bioactive substances from the bloodstream |
| 01/25/1992 | CA2087971A1 Composition providing improved clearance of bioactive substances from the bloodstream |
| 01/23/1992 | WO1992001059A1 Cdr grafted anti-cea antibodies and their production |
| 01/23/1992 | WO1992001047A1 Methods for producing members of specific binding pairs |
| 01/23/1992 | WO1992000993A1 Isolation and purification of lung surfactant protein |
| 01/22/1992 | EP0467839A1 In vitro processing of fusion proteins |
| 01/22/1992 | EP0467700A2 Coconjugate vaccines comprising immunogenic protein, HIV related peptides, and anionic moieties |
| 01/22/1992 | EP0467536A2 Method of treating bladder cancer cells |
| 01/22/1992 | EP0466817A1 Recombinant trichosanthin and coding sequence |
| 01/21/1992 | WO1992001474A1 Heterobifunctional reagents and conjugates with oxaalkylene units for amphiphilic bridge structures |
| 01/21/1992 | US5082776 Method of producing an adult t cell leukemia virus fused antigen polypeptide |
| 01/21/1992 | CA2087163A1 Heterobifunctional reagents and conjugates with oxaalkylene units for amphiphilic bridge structures |
| 01/21/1992 | CA1294570C Monoclonal antibodies specifically directed against prosomal proteins |
| 01/20/1992 | WO1992001472A1 Multivalent anti-cytokine immunoglobulins |
| 01/20/1992 | CA2087541A1 Multivalent anti-cytokine immunoglobulins |
| 01/20/1992 | CA2047073A1 Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties |
| 01/20/1992 | CA2047043A1 Class ii protein of the outer membrane of neisseria meningitidis having immune enhancement properties |
| 01/20/1992 | CA2047031A1 Peptide-polysaccharide-protein conjugate vaccines |
| 01/17/1992 | WO1992001797A1 IMMUNOGLOBULIN PRODUCTION BY $i(TRICHODERMA) |
| 01/17/1992 | CA2084189A1 Immunoglobulin production by trichoderma |
| 01/17/1992 | CA2028526A1 Method for the purification of immunoreactive labeled thyroxine conjugates |
| 01/15/1992 | EP0466505A2 Artificial antibody |
| 01/15/1992 | EP0466222A1 Ribosome-inactivating proteins, inactive precursor forms thereof, a process for making and a method of using |
| 01/15/1992 | EP0465633A1 C4 binding protein fusion proteins |
| 01/15/1992 | EP0465602A1 METHOD FOR DETECTION AND/OR IDENTIFICATION OF $i(LYSSAVIRUS) INFECTIONS, CLONING AND EXPRESSION OF GENES CODING FOR PEPTIDES AND/OR FRAGMENTS OF PEPTIDES OF MOKOLA $i(LYSSAVIRUS), VACCINE AGAINST THE MOKOLA VIRUS AND/OR THE FAMILY OF $i(LYSSAVIRUSES) AS WELL AS METHOD FOR OBTAINING SAID VACCINE VIA |
| 01/15/1992 | CN1057785A Synthetic poly-ig receptor, receptor-antibody complexes, production and use thereof |
| 01/14/1992 | US5081034 Genetic engineering |
| 01/14/1992 | US5081028 Preparation of transformed hosts which express binding factor related polypeptides |
| 01/14/1992 | US5081010 Alcoholamine, ethylene oxide alkylphenol compound; medical diagnosis |
| 01/09/1992 | WO1992000329A1 Surface complexed lymphotoxin |
| 01/09/1992 | WO1992000092A1 Ligand for cd28 receptor on b cells and methods |
| 01/09/1992 | WO1992000055A1 Compositions and methods for the prevention and diagnosis of lyme disease |
| 01/09/1992 | CA2084413A1 Compositions and methods for the prevention and diagnosis of lyme disease |
| 01/08/1992 | EP0465104A1 Method for the immunological determination of the carboxyterminal propeptide of type I procollagen |
| 01/08/1992 | EP0464533A1 Fusionproteins with parts of immunoglobulins, their production and use |
| 01/08/1992 | EP0464175A1 Extracellular form of the human fibroblast growth factor receptor |
| 01/08/1992 | CN1057672A Immobilization of biomolecules by enhanced electrophoretic precipitation |
| 01/07/1992 | US5079361 Crosslinking Of Polypeptides Or Proteins With A Reagent Containing A Vinyl Group Conjugated With An Aromatic Nitrogen Heterocycle |
| 01/07/1992 | US5078998 Hybrid ligand directed to activation of cytotoxic effector T lymphocytes and target associated antigen |
| 01/02/1992 | EP0463859A2 Immobilization of biomolecules by enhanced electrophoretic precipitation |
| 01/02/1992 | EP0463080A1 Cd8-based pharmaceuticals |
| 01/02/1992 | EP0179152B1 Diagnostic system for the detection of cytomegalovirus |
| 12/31/1991 | US5077392 Process for activation of recombinant protein produced by prokaryotes |
| 12/31/1991 | US5077195 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor |
| 12/27/1991 | EP0462246A1 Oligomeric immunoglobulins |
| 12/26/1991 | WO1991017773A3 New protein-polycation conjugates |
| 12/24/1991 | US5075211 Complexing antibodies with oligopeptides, blood screening |
| 12/24/1991 | US5075108 Acylation of mephalan by an anhydride |
| 12/22/1991 | CA2044858A1 Method of treating bladder cancer cells |
| 12/18/1991 | EP0461177A1 Human intra-acrosomal sperm antigen for use in a contraceptive vaccine |
| 12/18/1991 | EP0461159A1 Il-2 analogs containing n-linked glycosylation sites |
| 12/17/1991 | US5073627 Animal growth regulator |
| 12/14/1991 | WO1991019745A1 Chimeric toxins with improved inter-domain geometry |
| 12/14/1991 | CA2083487A1 Chimeric toxins with improved inter-domain geometry |
| 12/12/1991 | WO1991019739A1 Multivalent antigen-binding proteins |
| 12/12/1991 | WO1991019001A1 Immunodiagnostic assay for rheumatoid arthritis |
| 12/12/1991 | WO1991018983A1 Recombinant protein which binds to a complex viral antigen of hiv-1 |
| 12/12/1991 | WO1991018982A1 Type ii interleukin-1 receptors |
| 12/12/1991 | WO1991018981A2 Neurotropic growth factors comprising a homeobox peptide |
| 12/12/1991 | WO1991018928A1 Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type i (hiv-1) gp120 and methods of use |
| 12/12/1991 | WO1991018926A1 PROTEIN D - AN IgD-BINDING PROTEIN OF HAEMOPHILUS INFLUENZAE |
| 12/12/1991 | WO1991018922A1 16 kDa SURFACE PROTEIN OF $i(P. FALCIPARUM) |
| 12/12/1991 | CA2082529A1 Immunodiagnostic assay for rheumatoid arthritis |
| 12/12/1991 | CA2064829A1 Multivalent antigen-binding proteins |
| 12/12/1991 | CA2044201A1 Inactive precursor forms of ribosome inactivating proteins, a process for making and a method of using |
| 12/11/1991 | EP0460846A1 Type II interleukin-1 receptors |
| 12/11/1991 | EP0460709A1 AraB promoters and method of producing polypeptides, including cecropins, by microbiological techniques |
| 12/11/1991 | EP0460190A1 Method for detecting malignant diseases. |
| 12/11/1991 | EP0460101A1 Immobilized cytokines |
| 12/11/1991 | EP0235187B1 Polypeptides and antibodies characteristic of the papillomavirus, methods of diagnosis and vaccines in which they are used |
| 12/10/1991 | US5071963 Interferon-induced human (2'-5') oligo a synthetase |
| 12/10/1991 | US5071954 Used for immunization of animals and purification of specific antibodies; purity |
| 12/10/1991 | US5071761 Dna sequence coding for human lymphoblastoid interferons |
| 12/04/1991 | EP0459779A1 Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) GP120 and methods of use |